As of 2025-07-10, the EV/EBITDA ratio of Guangxi Liuzhou Pharmaceutical Co Ltd (603368.SS) is 9.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 603368.SS's latest enterprise value is 11,224.58 mil CNY. 603368.SS's TTM EBITDA according to its financial statements is 1,180.74 mil CNY. Dividing these 2 quantities gives us the above 603368.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 9.9x | 8.9x |
| Forward P/E multiples | 5.8x - 7.9x | 7.0x |
| Fair Price | 10.24 - 18.30 | 14.94 |
| Upside | -40.2% - 6.8% | -12.8% |
| Date | EV/EBITDA |
| 2025-05-07 | 9.53 |
| 2025-05-06 | 9.50 |
| 2025-04-30 | 9.44 |
| 2025-04-29 | 9.46 |
| 2025-04-28 | 9.31 |
| 2025-04-25 | 9.42 |
| 2025-04-24 | 9.43 |
| 2025-04-23 | 9.45 |
| 2025-04-22 | 9.43 |
| 2025-04-21 | 9.39 |
| 2025-04-18 | 9.39 |
| 2025-04-17 | 9.39 |
| 2025-04-16 | 9.37 |
| 2025-04-15 | 9.41 |
| 2025-04-14 | 9.38 |
| 2025-04-11 | 9.36 |
| 2025-04-10 | 9.37 |
| 2025-04-09 | 9.32 |
| 2025-04-08 | 9.27 |
| 2025-04-07 | 9.11 |
| 2025-04-03 | 9.71 |
| 2025-04-02 | 9.74 |
| 2025-04-01 | 9.72 |
| 2025-03-31 | 9.63 |
| 2025-03-28 | 9.73 |
| 2025-03-27 | 9.78 |
| 2025-03-26 | 9.94 |
| 2025-03-25 | 9.98 |
| 2025-03-24 | 9.87 |
| 2025-03-21 | 9.87 |
| 2025-03-20 | 10.00 |
| 2025-03-19 | 10.11 |
| 2025-03-18 | 10.03 |
| 2025-03-17 | 9.98 |
| 2025-03-14 | 10.01 |
| 2025-03-13 | 10.00 |
| 2025-03-12 | 9.67 |
| 2025-03-11 | 9.70 |
| 2025-03-10 | 9.78 |
| 2025-03-07 | 9.55 |
| 2025-03-06 | 9.57 |
| 2025-03-05 | 9.52 |
| 2025-03-04 | 9.54 |
| 2025-03-03 | 9.50 |
| 2025-02-28 | 9.50 |
| 2025-02-27 | 9.59 |
| 2025-02-26 | 9.59 |
| 2025-02-25 | 9.53 |
| 2025-02-24 | 9.63 |
| 2025-02-21 | 9.68 |